E Santoro

Summary

Affiliation: Istituto di Ricerche Farmacologiche Mario Negri
Country: Italy

Publications

  1. ncbi [Using podcasts for the cardiologist's education and update]
    Eugenio Santoro
    Laboratorio di Informatica Medica, Dipartimento di Epidemiologia, Istituto di Ricerche Farmacologiche Mario Negri, Milano
    Recenti Prog Med 99:163-70. 2008
  2. ncbi [Podcasts, wikis and blogs: the web 2.0 tools for medical and health education]
    Eugenio Santoro
    Laboratorio di Informatica Medica, Dipartimento di Epidemiologia, Istituto Ricerche Farmacologiche Mario Negri, Milano
    Recenti Prog Med 98:484-94. 2007
  3. ncbi Internet and information on breast cancer: an overview
    E Santoro
    Laboratory of Medical Informatics, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    Breast 12:424-31. 2003
  4. ncbi [Using Web 2.0 technologies and social media for the cardiologist's education and update]
    Eugenio Santoro
    Laboratorio di Informatica Medica, Dipartimento di Epidemiologia, Istituto di Ricerche Farmacologiche Mario Negri, Milano
    G Ital Cardiol (Rome) 12:174-81. 2011
  5. ncbi The DEC-net European register of paediatric drug therapy trials: contents and context
    Chiara Pandolfini
    Laboratory for Mother and Child Health, Mario Negri Pharmacological Research Institute, Via G La Masa 19, 20156 Milan, Italy
    Eur J Clin Pharmacol 64:611-7. 2008
  6. ncbi Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: analysis of the GISSI-3 database
    Fausto Avanzini
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche, Mario Negri, Milano, Italy
    Am Heart J 144:1018-25. 2002
  7. ncbi DEC-net: the development of the European register of clinical trials on medicines for children
    Eugenio Santoro
    Laboratory of Medical Informatics, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Clin Trials 3:366-75. 2006
  8. ncbi Cost-effectiveness analysis of early lisinopril use in patients with acute myocardial infarction. Results from GISSI-3 trial
    M G Franzosi
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Pharmacoeconomics 13:337-46. 1998
  9. ncbi Telecommunication technology for the management of large scale clinical trials: the Gissi experience
    E Santoro
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    Comput Methods Programs Biomed 60:215-23. 1999
  10. ncbi Clinical value of 12-lead electrocardiography to predict the long-term prognosis of GISSI-1 patients
    Francesco Mauri
    Division of Cardiology, Ospedale Niguarda Ca' Granda, Milano, Italy
    J Am Coll Cardiol 39:1594-600. 2002

Collaborators

Detail Information

Publications17

  1. ncbi [Using podcasts for the cardiologist's education and update]
    Eugenio Santoro
    Laboratorio di Informatica Medica, Dipartimento di Epidemiologia, Istituto di Ricerche Farmacologiche Mario Negri, Milano
    Recenti Prog Med 99:163-70. 2008
    ..The purpose of this paper is to describe what podcasting and podcasts are, and how they are currently used to educate and update cardiologists and health professionals working in the cardiology field...
  2. ncbi [Podcasts, wikis and blogs: the web 2.0 tools for medical and health education]
    Eugenio Santoro
    Laboratorio di Informatica Medica, Dipartimento di Epidemiologia, Istituto Ricerche Farmacologiche Mario Negri, Milano
    Recenti Prog Med 98:484-94. 2007
    ..Other studies are needed to evaluate the reliability and the accuracy of the medical contents posted online through the web 2.0 services...
  3. ncbi Internet and information on breast cancer: an overview
    E Santoro
    Laboratory of Medical Informatics, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    Breast 12:424-31. 2003
    ..Finding high-quality breast cancer literature and websites is relatively easy using appropriate indexes such as Cancerlit, MedlinePlus, and Cancerlinks...
  4. ncbi [Using Web 2.0 technologies and social media for the cardiologist's education and update]
    Eugenio Santoro
    Laboratorio di Informatica Medica, Dipartimento di Epidemiologia, Istituto di Ricerche Farmacologiche Mario Negri, Milano
    G Ital Cardiol (Rome) 12:174-81. 2011
    ..This review provides some background on the evolution of Web 2.0 and social media and describes the most interesting applications of Web 2.0 (and its features) both in the medical and cardiology fields...
  5. ncbi The DEC-net European register of paediatric drug therapy trials: contents and context
    Chiara Pandolfini
    Laboratory for Mother and Child Health, Mario Negri Pharmacological Research Institute, Via G La Masa 19, 20156 Milan, Italy
    Eur J Clin Pharmacol 64:611-7. 2008
    ..To describe the results and conclusions of DEC-net, an international, publicly available register of paediatric drug therapy clinical trials, and to assess which paediatric health areas are covered by research and by which trial types...
  6. ncbi Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: analysis of the GISSI-3 database
    Fausto Avanzini
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche, Mario Negri, Milano, Italy
    Am Heart J 144:1018-25. 2002
    ..Pathophysiological studies, however, suggest potential harm in excessive reduction of blood pressure (BP) in hypertensive patients with ischemic heart disease...
  7. ncbi DEC-net: the development of the European register of clinical trials on medicines for children
    Eugenio Santoro
    Laboratory of Medical Informatics, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Clin Trials 3:366-75. 2006
    ..Several general clinical trial registers have been developed, but none are dedicated to children. A web-based register of trials on drug therapy in children was therefore developed...
  8. ncbi Cost-effectiveness analysis of early lisinopril use in patients with acute myocardial infarction. Results from GISSI-3 trial
    M G Franzosi
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Pharmacoeconomics 13:337-46. 1998
    ..The cost effectiveness of early treatment with lisinopril of a relatively unselected population of patients with acute MI compares very favourably with that of other therapies judged to be worthwhile by the medical community...
  9. ncbi Telecommunication technology for the management of large scale clinical trials: the Gissi experience
    E Santoro
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    Comput Methods Programs Biomed 60:215-23. 1999
    ..The system was successfully adopted in the GISSI-3 trial (200 Coronary Care Units and 19,394 patients enrolled), in the European arm of the CORE trial and it is currently being used in the GISSI-Prevenzione trial...
  10. ncbi Clinical value of 12-lead electrocardiography to predict the long-term prognosis of GISSI-1 patients
    Francesco Mauri
    Division of Cardiology, Ospedale Niguarda Ca' Granda, Milano, Italy
    J Am Coll Cardiol 39:1594-600. 2002
    ..CONCLUSIONS: At 10 years, the survival rate appears to be related to the extent of myocardial injury, as evaluated by ST-segment elevation on the admission ECG...
  11. ncbi Ergometric score systems after myocardial infarction: prognostic performance of the Duke Treadmill Score, Veterans Administration Medical Center Score, and of a novel score system, GISSI-2 Index, in a cohort of survivors of acute myocardial infarction
    Massimo Villella
    Cardiology Department, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy
    Am Heart J 145:475-83. 2003
    ....
  12. ncbi Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial
    Giovanni Pedrazzini
    Division of Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland
    Am Heart J 155:388-94. 2008
    ..Furthermore, the 5-year survival analysis of GISSI-3 patients is reported...
  13. ncbi [A model for integrating biomedical research information]
    Eugenio Santoro
    Recenti Prog Med 95:207-9. 2004
    ..The model is restricted to the US, but could easily be applied in Europe and, in particular, in Italy...
  14. ncbi Treatment for isolated loco-regional recurrence of gastric adenocarcinoma: does surgery play a role?
    Fabio Carboni
    Department of Digestive Surgery and Liver Transplantation, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy
    World J Gastroenterol 11:7014-7. 2005
    ..To evaluate the role of surgical treatment for isolated loco-regional recurrences of operated gastric adenocarcinoma...
  15. ncbi [Surgical prospects for liver metastases]
    Giovanni Vennarecci
    Divisione di Chirurgia Digestiva Oncologica e dei Trapianti di Fegato Dipartimento di Chirurgia Oncologica, Istituto Regina Elena, Roma
    Chir Ital 59:27-39. 2007
    ..It is also possible to perform iterative liver resections and liver transplantation in selected cases of neuroendocrine liver metastases...
  16. ncbi Liver metastases from breast cancer. Results of surgical resection
    Massimo Carlini
    Department of Surgery, Division of Digestive Surgery and Liver Transplant, Regina Elena Institute for Cancer Research, Rome, Italy
    Hepatogastroenterology 49:1597-601. 2002
    ..Purpose of this study is to define the effectiveness of surgical resection of liver metastases from operated breast cancer...
  17. ncbi [The first European registry for pediatric clinical trials: DEC-net]
    Maurizio Bonati
    Istituto Mario Negn Milano
    Assist Inferm Ric 23:91-2. 2004